Summit backs Viroclinics Biosciences
Summit Partners has made an investment in Viroclinics Biosciences, a Dutch contract research organization serving the global biopharmaceutical industry.
Summit Partners has made an investment in Viroclinics Biosciences, a Dutch contract research organization serving the global biopharmaceutical industry.
Copyright PEI Media
Not for publication, email or dissemination